As global markets navigate geopolitical tensions and economic uncertainties, the Asian stock market remains a focal point for investors seeking value opportunities amid these broader challenges. Identifying undervalued stocks in such an environment involves assessing companies with strong fundamentals that may be temporarily overlooked, offering potential for growth as market conditions stabilize.
Top 10 Undervalued Stocks Based On Cash Flows In Asia
| Name |
Current Price |
Fair Value (Est) |
Discount (Est) |
|---|---|---|---|
| SHIFT (TSE:3697) |
¥661.40 |
¥1283.92 |
48.5% |
| SEERS (KOSDAQ:A458870) |
₩51900.00 |
₩99983.00 |
48.1% |
| Rayhoo Motor DiesLtd (SZSE:002997) |
CN¥29.65 |
CN¥58.04 |
48.9% |
| NexTone (TSE:7094) |
¥1468.00 |
¥2892.72 |
49.3% |
| MicroPort Scientific (SEHK:853) |
HK$9.01 |
HK$17.92 |
49.7% |
| Lum Chang Creations (Catalist:LCC) |
SGD0.98 |
SGD1.96 |
49.9% |
| Jiangsu Yuyue Medical Equipment & Supply (SZSE:002223) |
CN¥31.78 |
CN¥61.86 |
48.6% |
| JAC Recruitment (TSE:2124) |
¥857.00 |
¥1690.72 |
49.3% |
| Higold Group (SZSE:001221) |
CN¥62.64 |
CN¥121.43 |
48.4% |
| DIGITAL HEARTS HOLDINGS (TSE:3676) |
¥843.00 |
¥1632.26 |
48.4% |
Here we highlight a subset of our preferred stocks from the screener.
Sichuan New Energy Power
Overview:Sichuan New Energy Power Company Limited operates in China focusing on wind power, photovoltaic power, and waste-to-energy power generation with a market cap of CN¥32.58 billion.
Operations:The company's revenue is primarily derived from its Lithium Battery Business at CN¥1.79 billion, Electricity Sales Business at CN¥1.23 billion, and Environmental Protection Business at CN¥1.01 billion.
Estimated Discount To Fair Value:46.1%
Sichuan New Energy Power is trading at CN¥17.65, significantly below its estimated future cash flow value of CN¥32.76, suggesting it may be undervalued based on cash flows. Despite a lower profit margin this year (14% vs 23.8%), revenue and earnings are projected to grow faster than the Chinese market at 21.6% and 31.3% annually, respectively. However, the company's share price has been highly volatile recently and net income decreased from last year to CN¥502.49 million.
Wus Printed Circuit (Kunshan)
Overview:Wus Printed Circuit (Kunshan) Co., Ltd. specializes in the production, sale, and after-sales services of printed circuit boards in China, with a market cap of CN¥197.02 billion.
Operations:The company's revenue primarily comes from the production and sale of various printed circuit boards within China.
Estimated Discount To Fair Value:33.1%
Wus Printed Circuit (Kunshan) is trading at CN¥102.38, which is below its estimated future cash flow value of CN¥153.03, highlighting potential undervaluation based on cash flows. The company's earnings grew by 51.7% over the past year and are forecast to grow significantly at 28.6% annually, outpacing the Chinese market growth rate of 26.8%. Despite a volatile share price recently, revenue growth projections remain robust at 26.2% per year.
Intco Medical Technology
Overview:Intco Medical Technology Co., Ltd. specializes in the R&D, production, and marketing of medical consumables, rehabilitation equipment, and physiotherapy care for both medical institutions and household use globally, with a market cap of CN¥37.43 billion.
Operations:The company's revenue segments include medical consumables, rehabilitation equipment, and physiotherapy care for healthcare institutions and household use across both domestic and international markets.
Estimated Discount To Fair Value:12.1%
Intco Medical Technology is trading at CN¥57.79, slightly below its estimated future cash flow value of CN¥65.73, suggesting potential undervaluation. The company's earnings are forecast to grow significantly at 52.7% annually, surpassing the Chinese market average of 26.8%. However, recent earnings showed a decline in net income from CN¥352.72 million to CN¥10.03 million year-over-year, reflecting challenges despite anticipated revenue growth outpacing the market rate at 17% per year.
Turning Ideas Into Actions
-
Click through to start exploring the rest of the 200 Undervalued Asian Stocks Based On Cash Flows now.
-
Got skin in the game with these stocks? Elevate how you manage them by using Simply Wall St's portfolio, where intuitive tools await to help optimize your investment outcomes.
-
Take control of your financial future using Simply Wall St, offering free, in-depth knowledge of international markets to every investor.
Want To Explore Some Alternatives?
-
Explore high-performing small cap companies that haven't yet garnered significant analyst attention.
-
Diversify your portfolio with solid dividend payers offering reliable income streams to weather potential market turbulence.
-
Fuel your portfolio with companies showing strong growth potential, backed by optimistic outlooks both from analysts and management .
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Companies discussed in this article include SZSE:000155 SZSE:002463 and SZSE:300677.
This article was originally published by Simply Wall St .
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com
